Aquilo Capital Management, an investment group owned by US investor Marc Schneidman, has invested in Pieris Pharmaceuticals. Aquilo was one of five investors committing $32 million to the US-based group.
Subscribe
You will need a Premium+ Subscription to read this article.
Exclusive news, analysis and research on global family enterprise and private investment offices
Already have an account? Sign in
Already have an account? Sign in
You've reached the end.
Continue reading free articles by registering as a Member.
Or choose a Premium Plan.
Already have an account? Sign in